Tasigna litigation
Claims allege that the leukemia drug Tasigna causes rapidly progressive atherosclerosis, narrowing arteries in the legs, heart, and brain.
Free case review
What the claims allege
Canadian regulators required atherosclerosis warnings for Tasigna years before equivalent warnings appeared in the United States. Claims allege patients developed severe arterial disease, in some cases requiring amputation, without being told the drug could be the cause.
Injuries named in the litigation
- Peripheral arterial disease
- Heart attack and stroke
- Amputation from arterial occlusion
Who may qualify
If you took Tasigna for chronic myeloid leukemia and developed peripheral arterial disease, a heart attack, or a stroke, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.